Construct | Instrument | Method | Screening | T0 | T1 | T2 | T3 |
---|---|---|---|---|---|---|---|
Demographics | Self-composed questionnaire | Int | Â | X | Â | Â | Â |
Depression symptom severity 1 | IDS-SR | SR | X | X | X | X | X |
Depression diagnosis | MINI-S | Int | Â | X | X | X | X |
Childhood trauma | CTQ-SF | SR | X | Â | Â | Â | Â |
Subjective stress | PSS | SR | Â | X | X | X | X |
Insomnia | ISI | SR | Â | X | X | X | X |
Functioning and disability | WHODAS-II | SR | Â | X | X | X | X |
Anxiety symptom severity | BAI | SR | Â | X | X | X | X |
Suicidality | C-SSRS | Int | Â | * | * | * | * |
Alcohol use | AUDIT | SR | Â | X | Â | Â | Â |
Drug use | Self-composed questionnaire | SR | Â | X | Â | Â | Â |
Physical activity | IPAQ | SR | Â | X | Â | Â | Â |
Smoking | Self-composed questionnaire | SR | Â | X | Â | Â | Â |
Healthcare use | Self-composed questionnaire | Int | Â | Â | Â | Â | X |
Previous/current depression treatment | Self-composed questionnaire | SR | Â | X | Â | Â | Â |
Content of TAU 2 | Self-composed questionnaire | SR | Â | Â | Â | X | Â |
Content of TFT 2 | Self-composed questionnaire | SR | Â | Â | Â | X | Â |
PTSD/ASD diagnosis | MINI-S | Int | Â | X | Â | Â | Â |
Age and context CT exposure | MACE | SR | Â | X | Â | Â | Â |
Resilience | CD-RISC2 | SR | Â | X | Â | Â | Â |
Coping style | COPE-16 | SR | Â | X | Â | Â | Â |
Personality | NEO-FFI | SR | Â | X | Â | Â | Â |
Stressful life events | LTE | SR | Â | X | X | X | X |
Social support | SSL | SR | Â | X | X | X | X |
Cortisol | Hair | BM | Â | X | Â | X | Â |
Questions about hair sample | Self-composed questionnaire | Int | Â | X | Â | X | Â |
Epigenetic and inflammatory biomarkers | Blood | BM | Â | X | Â | X | Â |
Stress-related brain activity3 | Anatomic, resting state and task-based fMRI | BM | Â | X | Â | X | Â |